Research Areas | Center for Neuroscience Research
Attention Deficit Hyperactivity Disorder (ADHD) and Mood Disorders
Psychopharmacology Trials for Schizophrenia, Bipolar Disorder, Depression and ADHD
Adelaide Robb, M.D., is currently conducting research on pediatric bipolar disorder, schizophrenia, depression and ADHD. Through the FDA and in collaboration with sites around the world, Dr. Robb works to provide data that will:
- Establish evidence-based dosing strategies for medications in pediatric populations
- Characterize the pharmacokinetics and biodisposition of medications in children
- Examine the acute efficacy of medications in pediatric disorders
- Investigate the long-term effectiveness of pediatric medication treatment
- Characterize the short- and long-term safety of medications in pediatric populations.
For more information about the trials please visit Psychopharmacology Trials or call 202-476-6067.
Related News
-
Research, Education & Innovation Week 2024
April 22, 2024 -
Your guide to Research, Education & Innovation Week 2024
April 15, 2024 -
Driving pediatric breakthroughs through 2023
February 15, 2024